Heron Therapeutics Highlights Progress in Pain Management and CINV Franchises and Announces New Development Program
SAN DIEGO, Jan. 11, 2021 /PRNewswire/ — Heron Therapeutics, Inc. (Nasdaq: HRTX), a commercial-stage biotechnology company
SAN DIEGO, Jan. 11, 2021 /PRNewswire/ — Heron Therapeutics, Inc. (Nasdaq: HRTX), a commercial-stage biotechnology company